Literature DB >> 12887737

[The neuroprotection of resveratrol in the experimental cerebral ischemia].

Yong-jun Wang1, Fang He, Xiao-ling Li.   

Abstract

OBJECTIVE: To study the effect of resveratrol on cerebral infarct volume, cerebral edema as well as the expression of nuclear fac for (NF-kappaB) p65 in the experimental permanent middle cerebral artery occlusion.
METHODS: A middle cerebral artery occlusion model was constructed in 20 Wistar rats with Longa's method. Then the 20 rats were divided into 4 groups: control group, and 3 resveratrol groups (resveratrol of the concentrations of 10(-8) g/kg, 10(-7) g/kg, and 10(-6) g/kg were injected intravenously) (group 1- 4). The area of infarct was examined by 2,3,5-triphenyltetrazolium chloride (TTC) staining. The water content was calculated by dry and wet weight method. The expression of NF-kappaB p65 was investigated with immunohistochemistry.
RESULTS: The ischemic volume was 241 +/- 36, 222 +/- 39, 126 +/- 16, and 128 +/- 19 * in the groups 1 - 4 respectively, and the volume ratio was 0.49 +/- 0.04, 0.47 +/- 0.04, 27 +/- 0.02, and 0.43 +/- 0.02 respectively. The brain water content was 83.5% +/- 1.5%, 82.9% +/- 1.4%, 79.5% +/- 1.5%, and 79.9% +/- 1.4% in groups 1 - 4 with a significant difference between 10(-7) g/kg resveratrol group and pure ischemia group and 10(-6) g/kg resveratrol group and pure ischemia group (both P < 0.05). NF-kappaB p65 was not expressed in the normal control group and sham operation group, and was expressed 2 hours after pure ischemia. The expression of NF-kappaB p65 positive cells was the most significant 12 hours after the pure ischemia and began to decrease 24 hours after ischemia.
CONCLUSION: Resveratrol has a neuroprotective effect on the ischemic brain. This effect is related to the inhabitation of expression of NF-kappaB p65.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887737

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  4 in total

1.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Authors:  Juma Hoshino; Eun-Jung Park; Tamara P Kondratyuk; Laura Marler; John M Pezzuto; Richard B van Breemen; Shunyan Mo; Yongchao Li; Mark Cushman
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

2.  Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.

Authors:  Lisa K Brents; Fabricio Medina-Bolivar; Kathryn A Seely; Vipin Nair; Stacie M Bratton; Luis Nopo-Olazabal; Ronak Y Patel; Haining Liu; Robert J Doerksen; Paul L Prather; Anna Radominska-Pandya
Journal:  Xenobiotica       Date:  2011-10-04       Impact factor: 1.908

Review 3.  Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia.

Authors:  Kiran S Panickar; Richard A Anderson
Journal:  Int J Mol Sci       Date:  2011-11-18       Impact factor: 5.923

Review 4.  Pleiotropic protective effects of phytochemicals in Alzheimer's disease.

Authors:  Sergio Davinelli; Nadia Sapere; Davide Zella; Renata Bracale; Mariano Intrieri; Giovanni Scapagnini
Journal:  Oxid Med Cell Longev       Date:  2012-05-28       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.